Impaired polymorphonuclear neutrophil (PMN) function may contribute to the onset of certain life-threatening bacterial and fungal infections in human immunodeficiency virus (HIV)-infected patients. Published data on PMN functional activity in HIV infection are controversial, possibly because most studies have involved PMNs isolated from their blood environment by means of various procedures that may differently affect surface receptor expression and thereby alter cellular responses. We therefore used flow cytometry to study the expression of adhesion molecules at the PMN surface, actin polymerization, and the oxidative burst of wholeblood polymorphonuclear neutrophils in 42 HIV-infected patients at different stages of the disease. These PMNs were activated in vivo, as demonstrated by increased expression UMAN polymorphonuclear neutrophils (PMNs) play a critical role in host defenses against bacterial and fungal infection.' Impairment of PMN functional activity may thus contribute to the onset of certain life-threatening bacterial and fungal infections in human immunodeficiency virus (H1V)-infected patients. Contradictory results on both PMN functions (chemotaxis, phagocytosis, and oxidative burst) and surface receptor expression (eg, CD1 1WCD18) have been reported in HIV infection. Several investigators have found that PMNs from HIV-infected patients show normal or even enhanced whereas others have found that both resting and stimulated PMNs have diminished activities.' These discrepancies could be due to the use of PMNs from patients at different stages of HIV disease and to the fact that most studies have involved PMNs isolated from their blood environment by means of various procedures, which may differently affect surface receptor expression and thereby alter cell response^.^ A recent study performed with PMNs in whole blood showed an enhanced PMN oxidative burst triggered by various bacterial species at an early stage of HIV infection."
By C. Elbim UMAN polymorphonuclear neutrophils (PMNs) play a critical role in host defenses against bacterial and fungal infection.' Impairment of PMN functional activity may thus contribute to the onset of certain life-threatening bacterial and fungal infections in human immunodeficiency virus (H1V)-infected patients. Contradictory results on both PMN functions (chemotaxis, phagocytosis, and oxidative burst) and surface receptor expression (eg, CD1 1WCD18) have been reported in HIV infection. Several investigators have found that PMNs from HIV-infected patients show normal or even enhanced whereas others have found that both resting and stimulated PMNs have diminished activities.' These discrepancies could be due to the use of PMNs from patients at different stages of HIV disease and to the fact that most studies have involved PMNs isolated from their blood environment by means of various procedures, which may differently affect surface receptor expression and thereby alter cell response^.^ A recent study performed with PMNs in whole blood showed an enhanced PMN oxidative burst triggered by various bacterial species at an early stage of HIV infection. " We thus used fresh whole blood from patients at different stages of HIV infection to study some of the essential factors in PMN bactericidal activity: (1) expression of cellular adhesion molecules at the PMN surface, especially LAM-l (Lselectin) and the p2 integrin CDllb/CDl8, which are involved in adherence to endothelial cells and in transendothelial migration to inflammatory sites"."; ( 2 ) H202 production by PMNs, which is critical for microbial killing'; (3) actin polymerization, which appears to be involved in both receptor m~bilization"~'~ and the oxidative b~r s t . '~. ' ' ,~~ These parameters were measured in whole blood, first without adding any stimulant to investigate the activation status of the PMNs and secondly after stimulation by N-formyl peptides to measure the activation capacity of PMNs in response to bacterial-derived products. In addition, because high levels of proinflammatory cytokines (tumor necrosis factor [TNF] , interleukin-l [IL-l], IL-6, and IL-8) have been found in certain stages of HIV infecti~n'~-'' and because these cytokines modulate membrane expression of adhesion mole- of the adhesion molecule CDllb/CD18, reduced L-selectin antigen expression, increased actin polymerization, and increased H202 production. The alterations were present in asymptomatic patients with CD4' cell counts greater than 500/pL and did not increase with the progression of the disease. Stimulation by bacterial N-formyl peptides showed dysregulation of L-selectin shedding and decreased H202 production after ex vivo priming with tumor necrosis factor a or interleukin-8 (IL-8). These latter impairments, which correlated with the decrease in CD4+ lymphocyte numbers and with IL-8 and IL-6 plasma levels, could contribute to the increased susceptibility of HIV-infected patients to bacterial infections. 0 1994 by The American Society of Hematology. cules2* and prime the PMN oxidative b~r s t ,~"~~ we sought a correlation between TNF, IL-l, IL-6, and IL-8 plasma levels and PMN functions.
MATERIALS AND METHODS

Reagents.
The reagents and sources were as follows: human recombinant TNFa (rhTNFa; 2 X IO5 U/mL) and human recombinant endothelial cell-derived IL-8 (Genzyme, Cambridge, MA); 2',7'-dichlorofluorescin-diacetate (DCFH-DA; Eastman Kodak, Rochester, NY); N-formyl-methionyl-leucyl-phenylalanine (fMLP), unlabeled phalloidin, fluorescein isothiocyanate (FITC)-phalloidin, and L-a lysophosphatidylcholine (Sigma Chemical CO, St Louis, MO); R-phycoerythrin-conjugated monoclonal mouse antihuman CDllb antibody (PE-anti CDIlb; Dakopatts a/s, Glostrup, Denmark); R-fluorescein-conjugated monoclonal mouse antibody to human LAM-l, L-selectin (FITC-anti Le&), and SimulTEST reagents (FITCIPE), ie, FITC-HLElIPE-LeuM3 (CD4YCD14, leucogate), FITC-y WE-y 2 (control), FITC-Leu4IPE-Leul2 (CD3/CD19), FITC-Leu4IPE-Leull + Leu19 (CD3/CD16 + CD56). FITC-Leu4/ PE-Leu3 (CD3/CD4), FITC-Leu4IPE-Leu2 (CD3/CD8), FITCLeu2IPE-HLADr (CD8/NA), FITC-Leu2IPE-Leul7 (CDWCD38) (Becton Dickinson Immunocytometry Systems, San Jose, CA).
Stock solutions of DCFH-DA (50 m o m ) and fMLP (lo-' mol/ L) were prepared in dimethylsulfoxide (DMSO) and stored at -20°C.
Lyophilized IL-8 was dissolved in phosphate-buffered saline (PBS; Pharmacia Fine Chemicals, Uppsala, Sweden) containing 0.1% sterile human albumin serum and stored at -80°C. The different solutions were diluted in PBS immediately before use.
Subjects. Forty-two HIV,-infected adults (18 females and 34 males; mean age, 38 ? 10 years) were studied. HIV seropositivity was determined by enzyme-linked immunosorbent assay (ELISA) and confirmed by Western blot analysis. Patients with ongoing infections, in particular opportunistic infections, which could affect neutrophil functions, were excluded. HIV infection was classified according to the Centers for Disease Control riter ria.^' Four groups of patients were studied: CDC class A I (n = 10; asymptomatic, CD4' cell count >500/pL; none of these patients received any significant medication); CDC class A2 (n = IO; asymptomatic or generalized lymphadenopathy; CD4' cell count 200 to 500/pL; 4 were receiving antiretroviral therapy as part of Delta clinical trial: zidovudine [AZT] with or without either stavudine [ddC] H 2 0 z production. H20z production was measured by using a flow cytometric assay derived from the technique described by Bass et aLZ8 One milliliter of fresh blood collected onto preservative-free lithium heparinate (IO U/mL) was preincubated for 15 minutes with 2',7'-DCFH-DA (100 pmoVL) in a water bath with gentle horizontal agitation at 37°C. DCFH-DA diffuses into the cells and is hydrolysed into 2',7'-dichlorofluorescin (DCFH); during the PMN oxidative burst, nonfluorescent intracellular DCFH is oxidized to highly fluorescent dichlorofluoresceine (DCF) by H202 in the presence of peroxidase." The samples were then incubated with either TNF (IO0 UlrnL) or IL-8 (50 ng/mL) diluted in PBS, or with PBS alone, at 37°C for 30 minutes. fMLP diluted in PBS (IO-' molL final concentration) or a similar dilution of DMSO was added for 5 minutes at 37°C. The reaction was stopped and red blood cells were lysed with FACS lysing solution. After one wash (400 g for 5 minutes), white blood cells were suspended in I % paraformaldehyde-PBS. The fixed samples were kept on ice until cytofluorometric analysis on the same day.
F-acfin content of PMNs. Whole-blood samples were either kept on ice or incubated with fMLP mom) or PBS for I minute at 37°C. White blood cells obtained after red blood cell lysis were fixed with 1% paraformaldehyde-PBS, and F-actin content was measured using a flow cytometric assay.29 One hundred microliters of the cell suspension was incubated for 30 minutes at 0°C in 100 pL of 8% paraformaldehyde and 200 p U m L of L-a lysophosphatidylcholine in PBS alone or supplemented with l mmoVL unlabeled phalloidin to measure nonspecific binding of FITC-phalloidin. FITCphalloidin (20 pmol/L) was then added to the suspension and incubation was continued for 30 minutes at 0°C. After one wash in PBS, the cells were resuspended in 1 % paraformaldehyde-PBS.
Determination of C D l l h and L-selectin e.rpression. Wholeblood samples were either kept on ice or incubated with fMLP ( I O " molL) or PBS at 37°C for 5 minutes. One hundred microliters of sample was then incubated with a combination of PE-anti-CD I I b and FITC-anti-Leu8 antibodies for 30 minutes at 4°C; red blood cells were lysed with FACS lysing solution. After one wash with ice-cold PBS, the cells were resuspended in 1 % paraformaldehyde-PBS and kept on ice until flow cytometric analysis. Nonspecific binding of antibody was determined on cells incubated with the came concentration of an isotypic control.
Flow cytometry analysis. We used a Becton Dickinson FACScan with a 15-mW, 488-nm argon laser. PMN functions were analyzed using Lysis11 software. Forward and side scatter were used to identify the granulocyte population and to gate out other cells and debris. The purity of the gated cells was assessed using FITC-or PEconjugated CD3, CD45, CD14, and CD15 antibodies (Becton Dickinson). Ten thousand events were counted per sample and the fluorescence pulses were amplified by 4-decade logarithmic amplifiers. The green fluorescence of DCF, FITC-phalloidin, and FITC-antiLeu8 was recorded from 515 nm to 545 nm; the red fluorescence of PE-anti-CD1 Ib was recorded from 563 to 607 nm. In all cases. unstained cells were used and the photomultiplier settings were adjusted so that the unstained cell population appeared in the lower left-hand comer of the fluorescence display. In the dual-color analysis, single-cell controls were used to optimize signal compensation. All the results were obtained with a constant photomultiplier gain. The median fluorescence intensity was used to quantitate the responses. The effect of agonists on H 2 0 2 production was calculated using a stimulation index (SI = ratio of median fluorescence intensity of stimulated cells to that of unstimulated cells). Dual-color identification of lymphocyte subsets was performed using SimullSET software. Before acquisition, Autocomp was run to adjust gain setting$ and fluorescence compensation with caliBRITE beads (Becton Dickinson). Leucogate lets SimulSET automatically "gate" on lymphocytes in samples. The simulTEST control reagent was used to establish the marker settings for negative immunofluorescence.
Cytokine as.say.s. Blood was collected into sterile EDTA-treated vacuum tubes, transported on ice to the laboratory, and immediately centrifuged at 1,500g for 15 minutes at 4°C to avoid cytokine synthesis in vitro.3" Plasma samples were stored at -70°C for no longer than 15 days before assay. Cytokines in plasma were assayed in duplicate using an immunoradiometric assay for TNFa with a detection limit of 15 pg/mL (Medgenix, Brussels, Belgium) and immunoenzymatic assays for IL-6, IL-ID, and IL-8 with detection limits of 3 pg/mL (Medgenix for IL-6 and IL-IO; British Biotechnology [Abingdon, UK] for IL-8). The assays were standardized by compwing the results to those for standards from the National Institute for Biological Standards and Control (UK). Cytokine recovery was 102% 2 4% from normal plasma spiked with recombinant human cytokines.
Statistical analysis. All results are expressed as the mean 2 standard error of the mean (SEM). The group means were compared by analysis of variance followed by a multiple comparison of means by Fisher's least significant difference procedure. P values of .05 or less were considered significant. Correlations were identified by the Spearman rank correlation coefficient ( p ) .
RESULTS
PMNs and lymphocyte counts in HIV-infected patients. As shown in Table 1 the normal range. CD8+ cell counts were significantly increased in asymptomatic patients with normal CD4+ cell counts (group 1) relative to healthy controls. Moreover, the percentage of CD8' lymphocytes that expressed CD38 or HLADr antigens was significantly increased in all the patient groups relative to the healthy control subjects, and was inversely proportional to the CD4' cell counts, as previously described3' ( p = .74, P = ,0001 and p = .60, P = .0001 for the percentage of CDWCD38 and CD8/HLADr, respectively).
Expression of adhesion molecules at the PMN su$ace. As activation of neutrophils by various stimuli results in a decrease in L-selectin expression at the PMN surface" and an increase in CD1 lb?' we studied the expression of these molecules on resting PMNs and after stimulation with fMLP.
As shown in Table 2 , the median fluorescence intensity due to FITC-Leu8 antibody binding on resting PMN was significantly lower in group 1 than in the healthy control subjects and groups 3 and 4. After stimulation with fMLP, expression of L-selectin was no longer detectable on control PMN; median fluorescence intensity with FITC-Leu-8 antibody was always lower than the median fluorescence intensity of the control antibody (data not shown). In contrast, Lselectin was still detectable after fMLP stimulation on PMN from HIV-infected patients; median fluorescence intensity * Significantly different from group 1 ( P < .05).
increased with the stage of HIV infection and strongly correlated with the decrease in CD4' cell numbers ( p = .72, P = .0001) and the increase in T-cell activation markers ( p = .52, P = .001 and p = .49, P = .001 for the percentage of CD8KD38 and CDSMLADr, respectively) as well as IL-8 and IL-6 plasma levels ( p = .67, P = . OOO1 and p = .61, P = .0001 for IL-8 and IL-6, respectively). Incubation with PBS alone at 37°C did not significantly modify values relative to resting PMN maintained at 4°C.
As shown in Table 3 , CD1 l b expression on unstimulated PMNs at 4°C was significantly increased in all groups of HIV-infected patients relative to the healthy control subjects. No significant difference was observed between the four groups of patients. After 5 minutes of incubation with PBS at 37"C, CDllb expression was significantly higher than with PBS at 4°C in all groups of patients. More interestingly, 5 minutes of incubation with PBS alone at 37°C significantly increased the median fluorescence intensity in all the patient groups relative to the controls, and the degree of this temperature-induced increase in CD l 1 b expression was inversely proportional to the stage of HIV infection ( p = .3, P = .05). Stimulation with fMLP (1O"j m o m for 5 minutes at 37°C) induced a comparable strong increase in CD1 l b expression at the PMN surface in the controls and HIV-infected patient groups, reflecting normal maximal CDllb expression after PMN stimulation in HIV-infected patients.
H z 0 2 production by PMNs in whole blood. Unstimulated PMN (DCFH loading for 15 minutes at 37°C) from the healthy control subjects expressed low background fluores- For cence. As shown in Fig I , DCF fluorescence intensity was significantly higher with unstimulated PMN from HIV-infected patients.
As we have previously reported,'' tMLP (IO-" mol/L for S minutes), TNF (100 U/mL for 30 minutes), and L 8 (50 n g h L for 39 minutes) added separately to whole blood induced barely detectable HIOz production by PMNs from the control subjects. No significantly higher H202 production by PMNs from HIV-infected patients were observed. The SI did not differ significantly from I in all the groups of patients (data not shown). Preincubation of whole blood from the control subjects with 1 0 0 U/mL TNF for 30 minutes. followed by treatment with 10 (' mol/L fMLP for S minutes. induced a bimodal response in terms of DCF fluorescence intensity that has been shown by us earlier" (Fig 2) . Indeed, 51% ? 115% of PMNs had an S1 of 7.50 ? 1.38, whereas the remainder had an SI of I .47 5 0.26. Such a bimodal priming effect was also observed after preincubation of whole blood with 50 ng/mL IL-8 for 30 minutes, followed by fMLP. In these priming conditions, the hyperresponsive subpopulation was detectable with PMNs from 8 of the 10 patients in group 1 and 2 of the 10 patients in group 2. A unirnodal pattern was observed in the other patient groupc TNF on H202 production in response t o fMLP in an AIDS patient and a control subject. After loading with DCFH-DA at 37°C for 15 minutes, the samples were incubated with TNF at 100 UlmL for 30 minutes at 37°C and then with fMLP at mol/L for 5 minutes. Flow cytometric analysis of DCF fluorescence was performed as described in Materials and Methods. ( Fig 2) . I n addition. after TNF or IL-8 priming, the S1 of the total PMN population gradually decrcasecl with the stagc of HIV infection. with a decrease of about 50% i n the AIDS patients (Fig 3) respectively. In addition, slight (not significant) differences between the baseline levels of H 2 0 2 production were observed in the different groups of patients (22 ? 3.4. 16 ? 2.1. 17 -C I .6, and 23 2 7.3, respectively. for groups 1 through 4). However, the higher SI value of the control subjects also results, in part. from a lower baseline value (13 i 0.5). The decline in SI values col-related with the decrease in CD4' cell numbers and with 1L-8 and IL-6 plasma levels (Tablc 4).
Actin ~?~) l~~~~~~~~i~~~t i o~~ in wliolr-hlood PMN.v. Because actin polymerization has been involved in the upregulation of CD1 1 b/CD I8 molecules" and in the oxidative burst' i~' 5~' f ' after neutrophil activation, we studied PMN F-actin content. As shown in Table S . median fluorescence intensity of FITCphalloidin binding was significantly higher in patients from groups 1. 2. and 4 and close to the thre\hold of significance in group 3 relative to the control subjects.
There was no significant increaye in fluorescence intensity with the 5tage of HIV disease. However-. after 1 minute of incubation with PBS a t ?7T, the intcnsity 01' actin polymerization incrcnsed i n PMNs fr-om patients i n gI-oup 1 ancl 2 but not i n PMNs Cytokine plasma levels. As shown in Table 6 , TNF, IL-8, and IL-6 plasma levels increased with the stage of HIV disease. In particular, IL-8 plasma levels were significantly elevated in group 1 patients and correlated with the HIV disease stage ( p = .44, P = .002). IL-8, IL-6, and TNF plasma levels were significantly higher in the AIDS patients than in the control subjects. The largest increase was in IL-8, followed by IL-6 and TNF (5.7-, 3 5 , and 2.9-fold increases, respectively). IL-l was not significantly detectable in the controls or HIV-infected patients.
DISCUSSION
Our results show that circulating PMNs from HIV-infected patients are activated, even in the early, asymptomatic stage of the disease, when the CD4+ cell count is still greater than 500/pL. In fact, unstimulated PMNs from these patients showed increased CD1 1 b/CD 18 adhesion molecule expression, actin polymerization, and HzOZ production, and decreased L-selectin expression. These alterations did not increase with HIV disease severity; on the contrary, decreased L-selectin expression was only found at the earliest stage of HIV infection. In contrast, after stimulation with bacterial Nformyl peptides, PMNs from HIV-infected patients showed normal maximal CDllb expression and actin polymerization, but reduced L-selectin antigen shedding. Furthermore, after TNF and XL-8 priming, H202 production was impaired. These impairments correlated with the clinical stage of the disease, reflected by the CD4' cell counts, and also with IL-8 and IL-6 plasma levels. There have been conflicting reports on the activation status of circulating PMNs from HIV-infected patients. PMN activation is reflected by L-selectin shedding and an increase in CD1 lb/CD18 expression. L-selectin expression at the PMN surface has not, to our knowledge, previously been studied in HIV-infected patients. We found decreased L-selectin expression by unstimulated PMNs in the asymptomatic stage of HIV infection. An increase in CD1 lb/CD18 expression has been reported with whole-blood PMNs from CDC class IV HIV-infected patient^.^.' However, we extended this observation to all the patient groups including asymptomatic patients with CD4 greater than 500/pL and no significant differences were found between the different groups of patients. In addition, we found an increase in spontaneous H202 production by whole-blood PMNs from HIV-infected patients relative to healthy control subjects. This increase did not differ according to the stage of HIV infection. A similar pattern of increase in F-actin content was also observed in the HIV-infected patients. These latter results contrast with another report of similar oxidative burst level and F-actin content in isolated unstimulated PMNs from AIDS patients and healthy control subje~ts.~,' The apparent discrepancy could at least in part be due to methodologic differences. In particular, PMN isolation procedures have been shown to modify the surface expression of molecules that are not detectable in whole blood and that may be markers of PMN activation.' Activation due to the isolation procedures might thus mask differences between patients and healthy controls. Taken together, our findings obtained with whole-blood PMNs clearly demonstrate that these cells are activated in HIV-infected patients.
To assess PMN functions after stimulation, whole-blood PMNs were treated ex vivo with fMLP, a structural analog of bacterial metabolic products. In keeping with data reported by Capsoni et a16 for TNF-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-treated PMNs For personal use only. on October 22, 2017. by guest www.bloodjournal.org From in whole blood, fMLP-stimulated PMNs from HIV-infected patients showed normal maximal CD1 l b surface expression. In contrast, increased CD1 lb/CD18 expression in response to zymosan stimulation has been reported by Ellis et a14 with isolated PMNs from CDC class IV HIV-infected patients. We also found normal maximal actin polymerization in PMNs from HIV-infected patients after stimulation with mo1L fMLP for 1 minute, whereas Ryder et a15 reported an increased response of isolated PMNs to fMLP. As discussed above, isolation procedures could explain the differences observed between isolated and whole-blood PMNs. Changes in L-selectin expression after stimulation with fMLP differed from those in CD1 lb/CD18 expression and actin polymerization. Whereas fMLP-stimulated PMNs from HIV-infected patients expressed normal amounts of CD1 Ib at their surface and normal actin polymerization, L-selectin expression was dysregulated. In contrast to PMNs from healthy control subjects, L-selectin expression by PMNs from HIV-infected patients failed to decrease after fMLP stimulation. The extent of this abnormality increased with the stage of HIV infection, as shown by the correlation between median fluorescence intensity, the decrease in the CD4' cell count, and the increase in T-cell activation markers. There have been conflicting reports on the oxidative burst of PMNs isolated from HIV-infected patients in response to various stimuli. Some investigators have reported that in vitro 0;. production is significantly depressed after stimulation with fMLP.* In contrast, others have reported normal' or even enhanced oxidative We33 and others" have previously reported that fMLP, TNF, and IL-8 alone induce barely detectable H202 production by whole-blood PMNs from healthy control subjects, whereas pretreatment of blood with TNF or IL-8 strongly primes PMNs to produce H202 in response to fMLP.33 Here, fMLP, TNF, or IL-8 alone barely increased H202 production by PMNs from HIV-infected patients over baseline. These results point to an absence of in vivo PMN priming by cytokines and other inflammatory mediators, as described in other clinical settings such as bacterial infection^.^' Incidentally, these data also confirm the absence of ongoing bacterial infections in our patients. No data on the oxidative burst of PMNs from HIVinfected patients in response to stimulation after cytokine priming have previously been reported. In this study, a TNFor IL-&primed hyperresponsive PMN subpopulation was found after fMLP stimulation in control subjects in accordance with our previous data,33 but not in HIV-infected patients. Furthermore, the stimulation index of the overall PMN population was strongly decreased in AIDS patients relative to the control subjects. This impairment increased as HIV disease progressed, as shown by the strong correlation between the SI and the absolute CD4+ lymphocyte count ( Table   4 ).
The PMN functional abnormalities observed here may be due to several factors. The enhanced activation of circulating PMNs from HIV-infected patients could be a direct consequence of HIV infection; indeed, HIV DNA has been detected in PMN of HIV-infected patients by Gabrilovitch et al" and Spear et al," and mononuclear phagocytes infected in vitro with HIV, express increased surface levels of CD18 adhesion m~lecule.'~ Internalization of HIV by PMNs may occur, at least in part, by phagocytosis after opsonization with specific anti-HIV antibodies present after the seroconversion This could explain the basal activation of unstimulated PMNs from all the groups of HIV-infected patients tested, even those in the asymptomatic phase with CD4' cell counts greater than 500/pL, and activation state that did not increase with disease progression. Systemic release by activated monocytes or lymphocytes of cytokines reported to induce functional activation of circulating neutrophils in HIV-infected patients does not seem to be directly related to this basal activation. Indeed, we confirmed the increased levels of TNF, IL-6, and IL-8 in the plasma of HIV-infected patients, but, in contrast to CD1 1 b expression. actin polymerization, and H202 production, plasma levels of these cytokines increased with the progression of HIV disease. In addition, we have previously found that TNF, IL-6, and IL-8 alone do not enhance H202 production by PMN?' (personal data), suggesting that other products play a role in both the increased oxidative metabolism of unstimulated PMNs and the existence of a hyperresponsive subpopulation in some patients. It has recently been reported that monocytes infected with HIV, produce factors other than IL-I, IL-8, and TNF, which augment superoxide anion production by PMNs, particularly in the early stages of HIV infection." The decrease in L-selectin expression and the enhanced expression of CDllb and actin polymerization after incubation at 37°C phenomena observed in the early stages of HIV infection, could be related to such factors. In contrast, after in vitro priming with TNF and IL-8 and stimulation by bacterial peptides, H202 production by PMNs from HIV-infected patients showed strong negative correlations with IL-8 plasma level and the stage of the disease (Table 4 ). This decreased H202 production by IL-8-primed PMNs could be related to a "desensitization" phen~menon.~~ The large individual differences between TNF plasma level from HIV-infected patients could explain the lack of correlation between TNF plasma levels and HZ02 production by TNF-primed PMNs. However, synergy between the proinflammatory cytokines TNF, IL-6, and IL-8 could contribute to the desensitization phenomenon. The decrease in the shedding of L-selectin antigen after fMLP stimulation, which correlated strongly with HIV disease progression, the decrease in the CD4' cell count, and IL-8 and IL-6 plasma levels remain to be explained. Impaired CD4+ lymphocyte functions in HIV infection might contribute to PMN In physiologic conditions, circulating neutrophils are in a resting state. Migration of neutrophils to inflammatory sites involves a series of precisely regulated events. The selectin family of adhesion molecules on both neutrophils and endothelial cells are involved in the initial interaction of circulating neutrophils with the endothelium. In particular, L-selectin present on the neutrophil surface has been shown to participate in neutrophil rolling." In response to stimuli such as endothelium-derived c y t o k i n e~,~~ L-selectin is rapidly shed from the neutrophil surface and a p2 integrin-dependent phase of adhesion then occurs. In particular, upregulation of CD1 1 blCDl8 molecules at the cell surface is involved in the adhesion of neutrophils to the endothelium and in transFor personal use only. on October 22, 2017. by guest www.bloodjournal.org From endothelial migrati~n.~' Recent data show that neutrophil activation induces association of the actin-binding proteinactinin with the cytoplasmic domain of the 02-subunit of the integrin. This may link the actin cytoskeleton to the neutrophil membrane, a step necessary for enhanced adhesion and transendothelial migration. Actin polymerization has also been implicated in the cycling of receptors regulating the oxidative burst.I3.l4 All these phenomena are regulated in a precise manner, and excessive or inappropriate stimulation of neutrophils could lead to tissue injury, eg, vascular
Our results showing that unstimulated PMNs from HIV-infected patients express increased levels of CD1 Ib adhesion molecule, decreased levels of L-selectin, increased actin polymerization, and enhanced Hz02 production strongly suggest that circulating PMNs are activated in HIV-infected patients. Such a hyperactivation state may participate in the pathogenesis of certain leukocytoclastic vasculitis reported in HIV-infected patients.47 In addition, after bacterial peptide stimulation, L-selectin expression at the PMN surface was dysregulated, a phenomenon that could immobilize PMNs on the endothelium and hinder migration to inflammatory sites, thereby increasing susceptibility to bacterial infections. It has also been suggested that cytokine priming of neutrophils is critical for triggering of the oxidative b~r s t ,~~,~~ and our results suggest that susceptibility to infections in HIV-infected patients may be related in part to a failure of PMN oxidative metabolism to increase in response to inflammatory cytokines.
In conclusion, we found that whole-blood PMNs from HIV-infected patients are activated, even in the asymptomatic stage of infection when CD4' cell counts are greater than 500/pL. The degree of activation did not increase with HIV disease progression; on the contrary, some phenomena were more marked in the early asymptomatic phase. This could be related to the early immunologic responses to HIV and could contribute to vascular damage reported in HIV infection. We also found that L-selectin expression was dysregulated and that HZ02 production in response to bacterial peptides after TNF or IL-8 priming ex vivo was diminished. These functional abnormalities, which increased with HIV disease progression, could contribute to the increased susceptibility to bacterial infections in this setting.
